Skip to main content
. Author manuscript; available in PMC: 2018 Jan 9.
Published in final edited form as: J Surg Res. 2017 May 11;217:160–169. doi: 10.1016/j.jss.2017.05.020

Fig. 4.

Fig. 4

(A) Treatment of FVB/NJ WT and Mdr2−/− with miR-24 Vivo-Morpholino significantly increases hepatic Men1 expression compared with untreated FVB/NJ WT and Mdr2−/− control mice by qPCR (n = 3). (B) Ki-67 expression is significantly upregulated in FVB/NJ WT mice treated with miR-24 Vivo-Morpholino (n = 3). (* = P <0.05 versus FVB/NJ WT control samples; # = P < 0.05 versus Mdr2−/− samples).